ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,302.05
      0.65%
      US Tech 100
      18,352.80
      1.14%
      Dow Jones
      39,134.36
      0.18%
      Brent Oil
      81.875
      0.69%
      Bitcoin
      68,216.72
      0.43%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Napro Biotherapeutics (MM) (NPRO)

      7. Napro Biotherapeutics (MM) (NPRO) News

      NPRO

      Napro Biotherapeutics (NPRO)

      Napro Biotherapeutics (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NPRO
      DateTimeSourceHeadlineSymbolCompany
      05/04/20045:30PMPR Newswire (US)NaPro Changes Name to Tapestry PharmaceuticalsNASDAQ:NPRO
      04/27/20049:30AMPR Newswire (US)NaPro Announces Formation of Oncology Scientific Advisory BoardNASDAQ:NPRONapro Biotherapeutics (MM)
      04/22/20049:30AMPR Newswire (US)NaPro Announces Formation of Chemistry Advisory BoardNASDAQ:NPRONapro Biotherapeutics (MM)
      03/26/20048:00AMPR Newswire (US)NaPro Announces the Sale of Two Million Common SharesNASDAQ:NPRONapro Biotherapeutics (MM)
      03/22/200412:01PMPR Newswire (US)NaPro BioTherapeutics to Present at the Wells Fargo Securities Health Care ConferenceNASDAQ:NPRONapro Biotherapeutics (MM)
      03/11/20049:37AMPR Newswire (US)NaPro Reports Fourth Quarter and Full-Year 2003 ResultsNASDAQ:NPRONapro Biotherapeutics (MM)
      03/10/20049:35AMPR Newswire (US)Stephen K. Carter, M.D. Joins NaPro Board of DirectorsNASDAQ:NPRONapro Biotherapeutics (MM)
      01/12/20048:30AMPR Newswire (US)NaPro Announces Additions to Scientific Advisory BoardNASDAQ:NPRONapro Biotherapeutics (MM)
      12/24/20038:30AMPR Newswire (US)Court Rules in Favor of NaPro in Mylan Patent Infringement CaseNASDAQ:NPRONapro Biotherapeutics (MM)
      12/22/20034:01PMPR Newswire (US)NaPro BioTherapeutics Announces the Appointment of Anne Bailey as Vice President and General Manager, Genomics DivisionNASDAQ:NPRONapro Biotherapeutics (MM)
      12/12/20035:34PMPR Newswire (US)NaPro Completes Sale of Worldwide Paclitaxel Business to Mayne PharmaNASDAQ:NPRONapro Biotherapeutics (MM)
      12/04/20038:52AMPR Newswire (US)NaPro Awarded Phase I SBIR Grant for Research on Muscular DystrophyNASDAQ:NPRONapro Biotherapeutics (MM)
      11/19/20038:42AMPR Newswire (US)NaPro Unveils Targeted Therapeutic Platform for Lung, Breast, and Other Cancers at AACR-NCI-EORTC ConferenceNASDAQ:NPRONapro Biotherapeutics (MM)
      11/13/20038:28AMPR Newswire (US)NaPro Reports Third Quarter 2003 ResultsNASDAQ:NPRONapro Biotherapeutics (MM)
      11/12/20038:30AMPR Newswire (US)December 1 Trial Date Set in NaPro vs Mylan Patent Infringement CaseNASDAQ:NPRONapro Biotherapeutics (MM)
      11/10/20037:45AMPR Newswire (US)Reminder - NaPro BioTherapeutics to Present at The Wall Street Analyst Forum On November 10NASDAQ:NPRONapro Biotherapeutics (MM)
      11/07/200310:23AMPR Newswire (US)NaPro BioTherapeutics to Present at The Wall Street Analyst Forum On November 10NASDAQ:NPRONapro Biotherapeutics (MM)
       Showing the most relevant articles for your search:NASDAQ:NPRO